24/7 Customer Support

Lipid Nanoparticles Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2032

Global Lipid Nanoparticles Market: By Type (Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid Nano Emulsions (NLEs), Liposomes, Double-Layered or Bilayer Lipid Nanoparticles (BLNs) (Supported Lipid Bilayers (SLB) and Hybrid Lipid Bilayers (HLB)), Others); Application (Drug Delivery System, Gene Therapeutics (Cancer, Genetic Diseases, Infectious Diseases, and Others), Cosmetics, Research, Others); End Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetic manufacturers, and Others); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032

  • Published Date: 19-Jan-2024  |   Format: pdfpowerpointexcel  |  Report ID: AA0124756
    Delivery: 2 to 4 Hours
INFOGRAPHIC:
Lipid Nanoparticles Market

View Full Infographic

REPORT SCOPE

Report AttributeDetails
Market Size Value in 2023US$ 820.51 Million
Expected Revenue in 2032US$ 2,387.98 Million
Historic Data2019-2022
Base Year2023
Forecast Period2024-2032
UnitValue (USD Mn)
CAGR12.6%
Segments coveredBy Type, By Application, By End Users, By Region
Key Companies                                                                                                                                Acuitas Therapeutics, Alnylam Pharmaceuticals, Amgen Inc., Arbutus Biopharma, Arcturus Therapeutics, Arranta Bio, Avanti Polar Lipids, BioNTech SE, CordenPharma International, Dicerna Pharmaceuticals, Evonik Industries AG, Exelead, Gattefossé, Genevant Sciences, Helix Biotech, Inc., IOI Oleo GmbH, Lipoid GmbH, Merck KGaA, Moderna, Inc., Pfizer Inc., Precision NanoSystems Inc., PTS, Sanofi SA, Sirnaomics, Wacker Chemie AG, Other Prominent Players
Customization ScopeGet your customized report as per your preference. Ask for customization

LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.

SPEAK TO AN ANALYST